Advantage Trust Company’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$73.2K Buy
798
+300
+60% +$26.2K 0.03% 96
2026
Q1
$42.4K Hold
498
0.02% 84
2025
Q4
$39.4K Sell
498
-300
-38% -$23.5K 0.02% 84
2025
Q3
$63.8K Hold
798
0.03% 102
2025
Q2
$72.5K Buy
798
+300
+60% +$27.4K 0.04% 108
2025
Q1
$46.7K Hold
498
0.03% 105
2024
Q4
$45.3K Sell
498
-83
-14% -$7.92K 0.03% 109
2024
Q3
$60.3K Hold
581
0.04% 94
2024
Q2
$56.4K Hold
581
0.04% 105
2024
Q1
$52.3K Sell
581
-600
-51% -$50.8K 0.04% 107
2023
Q4
$94.1K Buy
+1,181
New +$88.8K 0.07% 74

Other funds holding CL

Advantage Trust Company's CL Position: Q2 2026 in Review

Advantage Trust Company increased its Colgate-Palmolive (CL) stake by 60% in Q2 2026, buying an estimated $26.2K and bringing the position to 798 shares worth $73.2K. The position accounts for 0.03% of the portfolio, ranked #96.

Advantage Trust Company first reported a position in CL in Q4 2023 and has held it in 11 quarters since. The position peaked at $94.1K in Q4 2023. 600 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Advantage Trust Company held 798 shares of Colgate-Palmolive worth $73.2K as of Q2 2026.
  • Advantage Trust Company bought 300 Colgate-Palmolive shares in Q2 2026, an estimated $26.2K.
  • Colgate-Palmolive made up 0.03% of Advantage Trust Company's portfolio in Q2 2026, its #96 holding.
  • Advantage Trust Company first reported a position in Colgate-Palmolive in Q4 2023 and has held it in 11 quarters since.
  • Advantage Trust Company's Colgate-Palmolive position peaked at $94.1K in Q4 2023.
  • 600 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Advantage Trust Company's 13F filing for Q2 2026, filed 17 Jul 2026.